[Strategies of breast cancer treatment based on determination of biological subtype].
作者信息
Semiglazov V F
出版信息
Vopr Onkol. 2011;57(5):542-52.
PMID:22238922
Abstract
摘要
相似文献
1
[Strategies of breast cancer treatment based on determination of biological subtype].基于生物学亚型判定的乳腺癌治疗策略
Vopr Onkol. 2011;57(5):542-52.
2
[New approaches to the treatment of breast cancer].[乳腺癌治疗的新方法]
Vopr Onkol. 2013;59(3):288-91.
3
[Locally advanced breast cancer (methods of treatment)].[局部晚期乳腺癌（治疗方法）]
Vopr Onkol. 2011;57(5):553-8.
4
Patients with anti-HER2 responsive disease: definition and adjuvant therapies.抗 HER2 反应性疾病患者：定义和辅助治疗。
Breast. 2011 Oct;20 Suppl 3:S132-4. doi: 10.1016/S0960-9776(11)70310-1.
5
[Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].[乳腺癌亚型及其内分泌代谢基础；实践层面]
Vopr Onkol. 2011;57(5):559-66.
6
[Systemic pharmacotherapy in breast cancer].[乳腺癌的全身药物治疗]
Orv Hetil. 2004 Jan 25;145(4):187-92.
7
Herceptin (trastuzumab): adjuvant and neoadjuvant trials.赫赛汀（曲妥珠单抗）：辅助治疗和新辅助治疗试验。
Isr Med Assoc J. 2006 Jun;8(6):416-21.
8
Neoadjuvant chemotherapy and targeted therapies: a promising strategy.新辅助化疗和靶向治疗：一种有前景的策略。
J Natl Cancer Inst Monogr. 2011;2011(43):116-9. doi: 10.1093/jncimonographs/lgr019.
9
[Neoadjuvant systemic therapy in breast cancer].[乳腺癌的新辅助全身治疗]
Orv Hetil. 2009 Jan 11;150(2):65-71. doi: 10.1556/OH.2009.28536.
10
The HER2 World: Better Treatment Selection for Better Outcome.HER2的世界：更优的治疗选择，更佳的治疗结果。
J Natl Cancer Inst Monogr. 2011;2011(43):82-5. doi: 10.1093/jncimonographs/lgr041.
Zotero 插件